Cart
sales@molnova.com
MDK-6983
CAS No. 1227476-98-3
MDK-6983( Autophagy inhibitor 6k | Compound 6k | MDK-6983 | MDK 6983 | MDK6983 )
Catalog No. M27899 CAS No. 1227476-98-3
MDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 283 | In Stock |
|
| 5MG | 249 | In Stock |
|
| 10MG | 368 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 770 | In Stock |
|
| 100MG | 1032 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMDK-6983
-
NoteResearch use only, not for human use.
-
Brief DescriptionMDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
-
DescriptionMDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
-
In Vitro——
-
In Vivo——
-
SynonymsAutophagy inhibitor 6k | Compound 6k | MDK-6983 | MDK 6983 | MDK6983
-
PathwayAutophagy
-
TargetAutophagy
-
Recptormicrotubule
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1227476-98-3
-
Formula Weight429.3
-
Molecular FormulaC22H18Cl2N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOc1ccc(Cl)cc1C(=O)N[C@H](Cc1ccccc1)C(=O)Nc1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wood AC, et al. Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program. Pediatr Blood Cancer. 2013;60(11):1860-1867.
molnova catalog
related products
-
Resveratrol analog 1
Resveratrol analog 1, an analog of Resveratrol, is a natural polyphenolic phytoalexin with antioxidant, anti-inflammatory, cardioprotective, and anti-cancer properties.
-
2,2-Dihydroxy chalco...
2,2'-Dihydroxy chalcone is a potent inhibitor of β-glucuronidase (IC50=1.6±0.2 μM) and lysozyme (IC50=1.4±0.2 μM) release from rat neutrophils stimulated with fMLP/CB.2,2'-Dihydroxy chalcone has inhibitory activity against Escherichia coli, Shigella fowleri, Staphylococcus albicans and Staphylococcus aureus.
-
Mefloquine hydrochlo...
A quinoline antimalarial drug that is structurally related to the antiarrhythmic agent quinidine; inhibits autophagy and has been recognized as a potential target for cancer therapy.
